Sorry, you need to enable JavaScript to visit this website.

Study Comparing Single Doses of Abrocitinib Tablets and Abrocitinib Liquid Medicine Taken Alone and After Famotidine Antacids

Study Comparing Single Doses of Abrocitinib Tablets and Abrocitinib Liquid Medicine Taken Alone and After Famotidine Antacids. A Phase 1, Randomized, Crossover Study to Evaluate Relative Bioavailability of Abrocitinib Oral Suspension and Effect of an Acid-Reducing Agent on the Bioavailability of Abrocitinib Commercial Tablet and to Assess the Taste of Abrocitinib Oral Formulations in Healthy Adult Participants
Aged 18 to 55 Years of Age.

Category & Conditions: Skin Diseases and Conditions
Medicine: abrocitinib (PF-04965842)
ClinicalTrials.gov Identifier (NCT): NCT04903093
Protocol ID: B7451061
    Share
PrintDownload
Open Plain Language Summary Result: Click here